Xu Y - Search Results

1

AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations.

Xu Y, Zhang X, Zhang R, Sun Y, Liu J, Luo C, Yang J, Fang W, Guo Q, Wei L. Xu Y, et al. Cancer Lett. 2023 Jul 10;566:216240. doi: 10.1016/j.canlet.2023.216240. Epub 2023 May 20. Cancer Lett. 2023. PMID: 37217071

2

Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling.

Yao JY, Xu S, Sun YN, Xu Y, Guo QL, Wei LB. Yao JY, et al. Among authors: xu s, xu y. Acta Pharmacol Sin. 2022 Apr;43(4):1033-1045. doi: 10.1038/s41401-021-00708-2. Epub 2021 Jun 29. Acta Pharmacol Sin. 2022. PMID: 34188177 Free PMC article.

3

The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma.

Xu Y, Guo Q, Wei L. Xu Y, et al. Cancers (Basel). 2021 Oct 12;13(20):5096. doi: 10.3390/cancers13205096. Cancers (Basel). 2021. PMID: 34680245 Free PMC article. Review.

4

CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma.

Yao J, Wang J, Xu Y, Guo Q, Sun Y, Liu J, Li S, Guo Y, Wei L. Yao J, et al. Among authors: xu y. Autophagy. 2022 Aug;18(8):1879-1897. doi: 10.1080/15548627.2021.2007027. Epub 2021 Dec 10. Autophagy. 2022. PMID: 34890308 Free PMC article.

5

Inhibition of TRPV4 remodels single cell polarity and suppresses the metastasis of hepatocellular carcinoma.

Liu J, Guo Y, Zhang R, Xu Y, Luo C, Wang R, Xu S, Wei L. Liu J, et al. Among authors: xu s, xu y. Cell Death Dis. 2023 Jun 28;14(6):379. doi: 10.1038/s41419-023-05903-z. Cell Death Dis. 2023. PMID: 37369706 Free PMC article.

6

Over-expression of COX-2 induces human ovarian cancer cells (CAOV-3) viability, migration and proliferation in association with PI3-k/Akt activation.

Gu P, Su Y, Guo S, Teng L, Xu Y, Qi J, Gong H, Cai Y. Gu P, et al. Among authors: xu y. Cancer Invest. 2008 Oct;26(8):822-9. doi: 10.1080/07357900801941860. Cancer Invest. 2008. PMID: 18798061

7

Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis.

Zhan S, Yang P, Zhou S, Xu Y, Xu R, Liang G, Zhang C, Chen X, Yang L, Jin F, Wang Y. Zhan S, et al. Among authors: xu r, xu y. Front Med. 2022 Apr;16(2):216-226. doi: 10.1007/s11684-022-0920-7. Epub 2022 Apr 13. Front Med. 2022. PMID: 35416630

8

A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX).

Cheng Y, Qin SK, Li J, Dai GH, Shen BY, Ying JE, Ba Y, Liang H, Wang XB, Xu Y, Zhou L, Ding KF, Qin YR, Yang SJ, Guan WX, Zheng H, Wang Q, Song H, Zhu YP. Cheng Y, et al. Among authors: xu y. J Cancer Res Clin Oncol. 2022 Mar;148(3):673-684. doi: 10.1007/s00432-021-03639-x. Epub 2021 Apr 17. J Cancer Res Clin Oncol. 2022. PMID: 33864522

9

[Effects of chlorotriptolide and triptonide on chromosome aberration and micronuclei of bone marrow cell in male rats].

Zhang JW, Liu QL, Lin N, Xu Y, Qian SZ. Zhang JW, et al. Among authors: xu y. Zhonghua Nan Ke Xue. 2002 Dec;8(6):408-10. Zhonghua Nan Ke Xue. 2002. PMID: 12593012 Chinese.

10

Shared and distinct electroencephalogram microstate abnormalities across schizophrenia, bipolar disorder, and depression.

Xue R, Li X, Deng W, Liang C, Chen M, Chen J, Liang S, Wei W, Zhang Y, Yu H, Xu Y, Guo W, Li T. Xue R, et al. Among authors: xu y. Psychol Med. 2024 May 13:1-8. doi: 10.1017/S0033291724001132. Online ahead of print. Psychol Med. 2024. PMID: 38738283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67,260 results

Search Page